The plummeting demand for Merck & Co.’s HPV vaccine Gardasil in China has forced the New Jersey drugmaker to rework its ...

Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. Merck, NYSE:MRK, is presenting new long term data on its ...

While clicking through Snapchat the other day, an ad for Merck’s new Versed campaign for Gardasil, its vaccine against the human papillomavirus (HPV), stopped my thumb in its tracks. As a researcher ...

Merck & Co. won’t be able to fully meet global demand for HPV vaccine Gardasil until after 2023 when it completes production of a couple of manufacturing plants. So for now, the drugmaker is again ...

FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey, U.S., July 12, 2018. REUTERS/Brendan McDermid/File Photo Feb 27 (Reuters) - Merck will lay off about 150 ...

Merck HPV vaccine Gardasil is poised for major growth by 2025 as new geographies and expanded labels add more people to its patient pool. Although the vaccine is 12 years old, Wolfe Research analysts ...

Gardasil is a vaccination that is being used routinely in males and females aged around 9 to 12 years, before they become sexually active. Gardasil offers protection against human papillomma virus ...

The U.S. Food and Drug Administration today approved a supplemental application for Gardasil 9 (Human Papillomavirus (HPV) 9-valent Vaccine, Recombinant) expanding the approved use of the vaccine to ...

The human papillomavirus (HPV) vaccine Gardasil is not linked to an increased risk of multiple sclerosis or any other similar central nervous system conditions, found a study published in JAMA today.